UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis
June 07, 2024
June 07, 2024
EL PASO, Texas, June 7 (TNSres) -- The University of Texas's El Paso campus issued the following news release:
Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body's tissues.
Md Nurunnabi, Ph.D., is an associate professor in UTEP's School of Pharmacy and the lead researcher on two studies published this June . . .
Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body's tissues.
Md Nurunnabi, Ph.D., is an associate professor in UTEP's School of Pharmacy and the lead researcher on two studies published this June . . .